se of the muscle relaxant Rocuronium in abdominal surgeries by video: comparison between small fractioned doses and continuous infusio
Not Applicable
- Conditions
- Muscle Tension, LaparoscopyE04
- Registration Number
- RBR-104b9shm
- Lead Sponsor
- Hospital Central do Exército
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adults over 18 years old; both sexes; ASA I, II and III - Anesthetic risk classification according to the American Society of Anesthesiologists [ASA1 (patient without comorbidities), ASA 2 ( patient with compensated comorbidities, without functional limitations), ASA 3 (patient with decompensated comorbidities with mild functional limitation.)]; surgery expected to last more than 1 hour
Exclusion Criteria
Known allergy to Rocuronium and/or Sugammadex; prior extensive surgery in the surgery cavity; locomotor or neurological disease; gestation; kidney or liver failure; refusal by the patient or his guardian; concomitant use of drugs that are known to interact with Rocuronium according to the manufacturer's package leaflet
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the total dose of rocuronium used to maintain deep muscle relaxation in intermittent bolus and continuous infusion techniques in laparoscopic surgeries
- Secondary Outcome Measures
Name Time Method Secondary outcomes are not expected